Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

BioNTech, Evotec, XPhyto - will the next rally start?

Germany's leading index DAX closed the previous day at 11,391 points, its highest level since March 2020. At the beginning of the week the index of the 30 largest German companies gained 317 points compared to Friday, representing a gain of 2.87%. In the USA Wall Street remain...

What’s Coming in Q4 – Adam (Fundamentalist) & Chris (Chartist) Explain

Recently I met an incredible trader and x-Bloomberg television anchor. His name is Adam Johnson and if you have not listened to his podcasts or followed his stock trading portfolio be sure to visit his website BullsEyeBrief.com Adam reached out to me a few weeks ago wa...

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...

Yes, the Waterfall Selling in S&P 500 Is Over Now

Just as I called for, there wasn't much S&P 500 downside left, and I am hugely profitable on the upside reversal from near yesterday's premarket lows. That's quite a turn in momentum, isn't it? So, is the correction in the last throws? I would certainly say so in terms of ...

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...

Jan 14th 2020, Silver Chartbook – An early stab

An early stab Participating in the markets is full of conflicts. This is due to the fact of the high variability of the market which has as such many choices and many moving parts. In this week´s case we have a confirmed short signal on the weekly and ...

What Do These Three Charts Have in Common?

Bob Moriarty of 321gold provides three charts for readers. Hint: That's what massive tops look like. Don't tell anyone else, I want to keep it a secret between you and me. Bob Moriarty founded 321gold.com , with his late wife, Barbara Moriarty, more...

Gold on the Cusp of Reaching $2,100

Chris Vermeulen, CEO & Founder of Technical Traders Ltd. , joins Tom Bodrovics at Palisade Radio to discuss the markets and Chris says, “This is the time to really be paying attention to the markets… It could be a bloodbath.” Chris is s...

Amgen Shares React Favorably to Enbrel Patent Case Victory

Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. On Friday, August 9, 2019, Amgen Inc. (AMGN:NASDAQ) announced that it had won its Enbrel patent case. The company advised that the U.S. District C...

After Biotech Dives Deeper Into Melanoma Data, It 'Continues to Impress'

Details from this clinical program are discussed, along with Q2/19 earnings and the next stock catalyst, in an H.C. Wainwright & Co. report. In an Aug. 23 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported the highlights from Targovax ASA's (TRVX:...
1 2 3 4 5 6 7 8 9 10 ...